Taking rivaroxaban is a risk factor for acute kidney disease and disorders in patients with coronary heart disease or non-valvular atrial fibrillation

被引：1
|
作者：
李文 [1 ]
机构：
[1] Dept Nephrol,Xuanwu Hosp, Capital Med Univ
来源：
China Medical Abstracts (Internal Medicine) | 2020年 / 37卷 / 04期
关键词：
AKD; Taking rivaroxaban is a risk factor for acute kidney disease and disorders in patients with coronary heart disease or non-valvular atrial fibrillation;
D O I：
暂无
中图分类号：
R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）]; R541.75 [];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To observe the risk of acute kidney disease and disorders (AKD) in patients with coronary heart disease or non-valvular atrial fibrillation who were taking rivaroxaban for the first time in our hospital.
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [1] Rivaroxaban is associated with higher risk of acute kidney disease in patients with non-valvular atrial fibrillation
    Li, Wen
    Meng, Jiali
    Dong, Xingtong
    Zhang, Jinhui
    Cui, Xiaohui
    Jia, Qiang
    Fu, Wenjing
    Jia, Linpei
    Zhang, Aihua
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (11): : 402 - 408
  • [2] Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
    Breithardt, Guenter
    Baumgartner, Helmut
    Berkowitz, Scott D.
    Hellkamp, Anne S.
    Piccini, Jonathan P.
    Lokhnygina, Yuliya
    Halperin, Jonathan L.
    Singer, Daniel E.
    Hankey, Graeme J.
    Hacke, Werner
    Becker, Richard C.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Califf, Robert M.
    Fox, Keith A. A.
    Patel, Manesh R.
    [J]. HEART, 2016, 102 (13) : 1036 - 1043
  • [3] Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
    Samaras, A.
    Vrana, E.
    Kartas, A.
    Rampidis, G.
    Doundoulakis, I.
    Fotos, G.
    Efthimiadis, G.
    Karvounis, H.
    Tzikas, A.
    Giannakoulas, G.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 421 - 421
  • [4] Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
    Athanasios Samaras
    Eleni Vrana
    Anastasios Kartas
    Dimitrios V. Moysidis
    Andreas S. Papazoglou
    Ioannis Doundoulakis
    George Fotos
    Georgios Rampidis
    Dimitrios G. Tsalikakis
    Georgios Efthimiadis
    Haralambos Karvounis
    Apostolos Tzikas
    George Giannakoulas
    [J]. BMC Cardiovascular Disorders, 21
  • [5] Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
    Samaras, Athanasios
    Vrana, Eleni
    Kartas, Anastasios
    Moysidis, Dimitrios, V
    Papazoglou, Andreas S.
    Doundoulakis, Ioannis
    Fotos, George
    Rampidis, Georgios
    Tsalikakis, Dimitrios G.
    Efthimiadis, Georgios
    Karvounis, Haralambos
    Tzikas, Apostolos
    Giannakoulas, George
    [J]. BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [6] RISK OF RECURRENT STROKE IN PATIENTS WITH ATRIAL-FIBRILLATION AND NON-VALVULAR HEART-DISEASE
    SAGE, JI
    VANUITERT, RL
    [J]. STROKE, 1983, 14 (04) : 537 - 540
  • [7] Cost-effectiveness of rivaroxaban versus warfarin in non-valvular atrial fibrillation patients with chronic kidney disease in China
    Liu, Lin
    Hong, Dongsheng
    Ma, Kuifen
    Lu, Xiaoyang
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 658 - 668
  • [8] Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease
    Coleman, Craig, I
    Baker, William L.
    Meinecke, Anna-Katharina
    Eriksson, Daniel
    Martinez, Brandon K.
    Bunz, Thomas J.
    Alberts, Mark J.
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (03) : 159 - 166
  • [9] Anticoagulation in patients with non-valvular atrial fibrillation (nvAF) and chronic kidney disease (CKD)
    Zeymer, Uwe
    Bonnemeier, Hendrik
    Wanner, Christoph
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (23) : 1642 - 1649
  • [10] The Choice of Anticoagulant Therapy in Patients With Non-Valvular Atrial Fibrillation and Chronic Kidney Disease
    Koziolova, N. A.
    Polyanskaya, E. A.
    Kolegova, I. I.
    [J]. KARDIOLOGIYA, 2017, 57 (01) : 76 - 85
12345